JHVIT Health Sciences I (JEHSX)

Fund Assets	n/a
Expense Ratio	1.04%
Min. Investment	$0.00
Turnover	n/a
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Annual
Ex-Dividend Date	Oct 23, 2025

Previous Close	25.95
YTD Return	14.31%
1-Year Return	28.47%
5-Year Return	28.30%
52-Week Low	20.79
52-Week High	27.41
Beta (5Y)	0.57
Holdings	173
Inception Date	n/a

About JEHSX

John Hancock Variable Insurance Trust Health Sciences Fund I is a mutual fund designed to provide investors with targeted exposure to the health sciences sector. The fund primarily invests at least 80% of its net assets in equity securities of companies involved in health care, such as biotechnology, pharmaceuticals, medical technology, and related industries. Emphasizing growth, it typically focuses on small-capitalization companies within the market capitalization range of the Russell 2000 Index, making it a specialized option for those seeking sector-specific opportunities. The fund is classified as non-diversified, meaning it can allocate its assets to a smaller number of issuers, which may increase risk due to higher exposure to individual companies or sub-sectors. Its structure is specifically engineered to serve as an underlying investment option for variable insurance products, supporting long-term capital appreciation for insurance contract holders. The fund plays a significant role in broadening the investment menu available to policyholders, allowing for portfolio diversification within the dynamic and innovative health sciences arena.

• Stock Exchange: Nasdaq
• Ticker Symbol: JEHSX
• Share Class: Series I
• Index: S&P 500 TR

Performance

JEHSX had a total return of 28.47% in the past year, including dividends. Since the fund's inception, the average annual return has been 6.20%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
JAFMX	Nav	0.99%
JAFKX	Series Ii	1.24%

Top 10 Holdings

48.29% of assets

Name	Symbol	Weight
Eli Lilly and Company - ELI LILLY and CO COMMON STOCK	LLY.US	14.30%
JOHNSON and JOHNSON COMMON STOCK USD1.0	JNJ.US	6.33%
UnitedHealth Group Incorporated - UNITEDHEALTH GROUP INC COMMON STOCK USD.01	UNH.US	5.95%
AbbVie Inc. - ABBVIE INC COMMON STOCK USD.01	ABBV.US	5.28%
Merck and Co. Inc. - MERCK + CO INC COMMON STOCK USD.5	MRK.US	4.21%
Gilead Sciences Inc. - GILEAD SCIENCES INC COMMON STOCK USD.001	GILD.US	2.95%
Thermo Fisher Scientific Inc. - THERMO FISHER SCIENTIFIC INC COMMON STOCK USD1.0	TMO.US	2.67%
Vertex Pharmaceuticals Incorporated - VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01	VRTX.US	2.38%
Bristol-Myers Squibb Company - BRISTOL-MYERS SQUIBB CO COMMON STOCK USD.1	BMY.US	2.22%
ABBOTT LABORATORIES COMMON STOCK	ABT.US	2.00%

Dividend History

Ex-Dividend	Amount	Pay Date
Oct 23, 2025	$3.23399	Oct 24, 2025
Oct 24, 2024	$1.70757	Oct 25, 2024
Oct 24, 2023	$1.26206	Oct 25, 2023
Oct 25, 2022	$3.23984	Oct 26, 2022
Oct 26, 2020	$3.20196	Oct 27, 2020
Aug 22, 2019	$1.97338	Aug 23, 2019

Data Sources: Tiingo and Finnhub

Historical data is provided by Tiingo. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error